Yi, D., Borre, C. I., Poleksic, M., Shukla, B. H., Fitzgerald, J., Khan, M. A., Bhambhvani, P., Sen, M., Morlote, D., Saha, A., Bailey, L., Sokolowski, D., Patgunarajah, U., Tobin, W., Young, J., Valinotti, J. S., Koster, M. J., Medina, A. A., Shah, M., Bennani, N. N., Moustafa, M. A., Hilal, T., Vassallo, R., Gruber, L., Dasari, S., Rech, K., Witzig, T., Ravindran, A., Goyal, G., Go, R., Abeykoon, J. (2025). KRAS mutations in histiocytic neoplasms: Mutation spectrum and response to MEK inhibition. Blood. https://doi.org/10.1182/blood-2025-6760